Published 1997 | Version v1.0.0
Journal Article Open
Sumatriptan Nasal Spray for Acute Migraine
The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.
Files (1.2 MB)
||1.2 MB||Preview Download|
1997When the item was originally created.